Christina UWINS

Dr. Christina UWINS

Royal Surrey NHS Foundation Trust, Guildford, Surrey, UK
orcid

Research Focus & Metrics

Academic Career Length

21Years (2006-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2020 in International Journal of Gynecological Cancer
Verified
Journal Article
Closed access
PDF file
CUChristina UWINS
Christina UWINS
GBGeetu Bhandoria
Geetu Bhandoria
TSTs Shylasree
Ts Shylasree
SBSimon Butler-Manuel
Simon Butler-Manuel
PEPatricia Ellis
Patricia Ellis
AMAgnieszka Michael
Agnieszka Michael
On March 11, 2020 the COVID-19 outbreak was declared a ‘pandemic’ by the World Health Organization. COVID-19 is associated with higher surgical morbidity and mortality. An array of guidelines on the management of cancer during this pandemic have been published since the first reports of the outbreak. This narrative review brings all the relevant information from the guidelines together into one document, to support patient care. We present a detailed review of published guidelines, statements, comments from peer-reviewed journals, and nationally/internationally recognized professional bodies and societies' web pages (in English or with English translation available) between December 1, 2019 and May 27, 2020. Search terms included combinations of COVID, SARS-COV-2, guideline, gynecology, oncology, gynecological, cancer. Recommendations for surgical and oncological prioritization of gynecological cancers are discussed and summarized. The role of minimally invasive surgery, patient perspectives, medico-legal aspects, and clinical trials during the pandemic are also discussed. The consensus is that elective benign surgery should cease and cancer surgery, chemotherapy, and radiotherapy should continue based on prioritization. Patient and staff face-to-face interactions should be limited, and health resources used efficiently using prioritization strategies. This review and the guidelines on which it is based support the difficult decisions currently facing us in gynecological cancer. It is a balancing act: limited resources and a hostile environment pitted against the time-sensitive nature of cancer treatment. We can only hope to do our best for our patients with the resources available to us.

1 April 2013 in European Journal of Obstetrics & Gynecology and Reproductive Biology
Verified
Journal Article
Closed access
JPJ. Pundir
J. Pundir
NKN. Krishnan
N. Krishnan
ASA. Siozos
A. Siozos
CUChristina UWINS
Christina UWINS
JKJ. Kopeika
J. Kopeika
TET. El-Toukhy
T. El-Toukhy

2 June 2024 in International Journal of Gynecological Cancer
Verified
Journal Article
Open access
PDF file
CUChristina UWINS
Christina UWINS
HAHasanthi Assalaarachchi
Hasanthi Assalaarachchi
KBKate Bennett
Kate Bennett
JRJames Read
James Read
ATAnil Tailor
Anil Tailor
SBSimon Butler-Manuel
Simon Butler-Manuel
Objective To establish the feasibility and safety of robotic interval debulking surgery following the MIRRORS protocol (robot-assisted laparoscopic assessment prior to robotic or open surgery) in women with advanced-stage ovarian cancer. MIRRORS is the first of three planned trials: MIRRORS, MIRRORS-RCT (pilot), and MIRRORS-RCT. Methods The participants were patients with stage IIIc-IVb epithelial ovarian cancer undergoing neo-adjuvant chemotherapy, suitable for interval debulking surgery with a pelvic mass ≤8 cm. The intervention was robot-assisted laparoscopic assessment prior to robotic or open interval debulking surgery (MIRRORS protocol). The primary outcome was feasibility of recruitment, and the secondary outcomes were quality of life (EORTC QLQC30/OV28, HADS questionnaires), pain, surgical complications, complete cytoreduction rate (%), conversion to open surgery (%), and overall and progression-free survival at 1 year. Results Overall, 95.8% (23/24) of patients who were eligible were recruited. Median age was 68 years (range 53–83). All patients had high grade serous histology and were BRCA negative. In total, 56.5% were stage IV, 43.5% were stage III, 87.0% had a partial response, while 13.0% had stable disease by RECIST 1.1. Median peritoneal cancer index was 24 (range 6–38). Following MIRRORS protocol, 87.0% (20/23) underwent robotic interval debulking surgery, and 13.0% (3/23) had open surgery. All patients achieved R<1 (robotic R0=47.4%, open R0=0%). No patients had conversion to open. Median estimated blood loss was 50 mL for robotic (range 20–500 mL), 2026 mL for open (range 2000–2800 mL) (p=0.001). Median intensive care length of stay was 0 days for robotic (range 0–8) and 3 days (range 3–13) for MIRRORS Open (p=0.012). The median length of stay was 1.5 days for robotic (range 1–17), 6 days for open (range 5–41) (p=0.012). The time to chemotherapy was as follows 18.5 days for robotic (range 13–28), 25 days for open (range 22–28) (p=0.139). Conclusions Robotic interval debulking surgery appears safe and feasible for experienced robotic surgeons in patients with a pelvic mass ≤8 cm. A randomized controlled trial (MIRRORS-RCT) will determine whether MIRRORS protocol has non-inferior survival (overall and progression-free) compared with open interval debulking surgery.

7 March 2006 in Electrophoresis
Verified
Journal Article
Closed access
PDF file
CUChristina UWINS
Christina UWINS
CDChristian Deitrich
Christian Deitrich
EAEvelyn Argo
Evelyn Argo
ESElizabeth Stewart
Elizabeth Stewart
IDIan Davidson
Ian Davidson
PCPhil Cash
Phil Cash

1 November 2014 in Pediatric Health, Medicine and Therapeutics
Verified
Journal Article
Open access
DHDavid Jr Hutchon
David Jr Hutchon
CUChristina UWINS
Christina UWINS
Early cord clamping was initially introduced as part of the package of care known as “active management of the third stage”, which was implemented to reduce postpartum hemorrhage. It has now been shown to provide no benefit to the mother and to result in harm to the neonate. The clinical trial evidence relating to delayed cord clamping compared to immediate cord clamping is presented and the physiological rationale for delayed cord clamping is discussed in this paper. Most organizations (eg World Health Organization (WHO), Royal College of Obstetricians and Gynaecologists (RCOG), Resuscitation Council (UK),The International Federation of Gynecology and Obstetrics (FIGO), International Confederation of Midwives, International Liaison Committee on Resuscitation (ILCOR) and the European Resuscitation Council) now advise a delay of 1–3 minutes before clamping the cord in term and preterm infants, and clinicians need to be aware of this change. Healthy neonates benefit from a more physiological and gentle transition from placental to pulmonary respiration, and we explain why this benefit should be provided to all neonates until there is any evidence to the contrary. The harm of early cord clamping is not limited to anemia and iron deficiency, and evidence for a wide range of possible harms of early cord clamping is presented. The need for resuscitation is one of the most common concerns, and ways of overcoming these concerns are described.

10 June 2024 in Clinical Oncology
Verified
Journal Article
Closed access
RKRebecca Karkia
Rebecca Karkia
TNT.R. Nyakunengwa
T.R. Nyakunengwa
CUChristina UWINS
Christina UWINS
ASAlexandra Stewart
Alexandra Stewart
HPHersha Patel
Hersha Patel
JCJ. Chatterjee
J. Chatterjee